{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:27:26Z","timestamp":1789064846457,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.hoc.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T09:15:28Z","timestamp":1461662128000},"page":"635-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Red Blood Cell Antibodies in Hematology\/Oncology Patients"],"prefix":"10.1016","volume":"30","author":[{"given":"Jeanne E.","family":"Hendrickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Tormey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hoc.2016.01.006_bib1","first-page":"155","article-title":"Conventional tube agglutination with polyethylene glycol versus Red Cell Affinity Column Technology (ReACT): a comparison of antibody detection methods","volume":"32","author":"Brumit","year":"2002","journal-title":"Ann Clin Lab Sci"},{"issue":"4 Suppl 1","key":"10.1016\/j.hoc.2016.01.006_bib2","first-page":"S17","article-title":"Automation in blood banking. Machines for clumping, sticking, and gelling","volume":"98","author":"Plapp","year":"1992","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.hoc.2016.01.006_bib3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1537-2995.1998.381098440861.x","article-title":"Evaluation of a new automated instrument for pretransfusion testing","volume":"38","author":"Morelati","year":"1998","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.hoc.2016.01.006_bib4","first-page":"221","article-title":"Evaluation of a solid-phase test for erythrocyte antibody screening of pregnant women, patients and blood donors","volume":"71","author":"Sallander","year":"1996","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.hoc.2016.01.006_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.hoc.2015.01.003","article-title":"Hemolysis from ABO incompatibility","volume":"29","author":"Simmons","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.transci.2010.12.013","article-title":"Molecular genetics and clinical applications for RH","volume":"44","author":"Flegel","year":"2011","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.hoc.2016.01.006_bib7","series-title":"Technical manual","first-page":"367","article-title":"Pretransfusion testing","author":"Downes","year":"2014"},{"issue":"3","key":"10.1016\/j.hoc.2016.01.006_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.hoc.2015.01.001","article-title":"Warm autoimmune hemolytic anemia","volume":"29","author":"Naik","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9","key":"10.1016\/j.hoc.2016.01.006_bib9","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/trf.12026","article-title":"A\u00a0major target for warm immunoglobulin G autoantibodies: the third external loop of Band 3","volume":"53","author":"Janvier","year":"2013","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2007.08.002","article-title":"Cold antibody autoimmune hemolytic anemias","volume":"22","author":"Petz","year":"2008","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.hoc.2016.01.006_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.hoc.2015.01.004","article-title":"Paroxysmal cold hemoglobinuria","volume":"29","author":"Shanbhag","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.hoc.2016.01.006_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1309\/LM1E9Z2QZEREPAI","article-title":"Detection and significance of Donath-Landsteiner antibodies in a 5-year-old female presenting with hemolytic anemia","volume":"41","author":"Sanford","year":"2010","journal-title":"Lab Med"},{"issue":"3","key":"10.1016\/j.hoc.2016.01.006_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.hoc.2015.01.002","article-title":"Cold agglutinin-mediated autoimmune hemolytic anemia","volume":"29","author":"Berentsen","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10","key":"10.1016\/j.hoc.2016.01.006_bib14","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/j.1537-2995.2008.01815.x","article-title":"Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans","volume":"48","author":"Tormey","year":"2008","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib15","first-page":"53","article-title":"Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome","volume":"13","author":"Guelsin","year":"2015","journal-title":"Blood Transfus"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib16","first-page":"21","article-title":"Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases","volume":"22","author":"Seyfried","year":"1990","journal-title":"Mater Med Pol"},{"issue":"7","key":"10.1016\/j.hoc.2016.01.006_bib17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1537-2995.2003.00443.x","article-title":"WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization","volume":"43","author":"Blumberg","year":"2003","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.hoc.2016.01.006_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1423-0410.1983.tb01886.x","article-title":"Immune response to chronic red blood cell transfusion","volume":"44","author":"Blumberg","year":"1983","journal-title":"Vox Sang"},{"issue":"11","key":"10.1016\/j.hoc.2016.01.006_bib19","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1537-2995.2007.01433.x","article-title":"Clinical predictors of alloimmunization after red blood cell transfusion","volume":"47","author":"Bauer","year":"2007","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.hoc.2016.01.006_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bmt.1704114","article-title":"Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation","volume":"32","author":"Perseghin","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.hoc.2016.01.006_bib21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/bmt.2013.196","article-title":"Minor RBC Ab and allo-SCT","volume":"49","author":"Booth","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1537-2995.2001.41010106.x","article-title":"Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?","volume":"41","author":"de la Rubia","year":"2001","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(19920101)69:1<252::AID-CNCR2820690141>3.0.CO;2-4","article-title":"Identification of previous erythrocyte alloimmunization and the type and screen at a large cancer center. A 4-year retrospective review","volume":"69","author":"Havemann","year":"1992","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2016.01.006_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tracli.2010.06.026","article-title":"Frequency of red blood cell alloimmunization in polytransfused patients at the university teaching hospital of VMali","volume":"17","author":"Baby","year":"2010","journal-title":"Transfus Clin Biol"},{"issue":"6","key":"10.1016\/j.hoc.2016.01.006_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.5581\/1516-8484.20130123","article-title":"Study of possible clinical and laboratory predictors of alloimmunization against red blood cell antigens in cancer patients","volume":"35","author":"Dinardo","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"8","key":"10.1016\/j.hoc.2016.01.006_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2016.01.006_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ajh.23877","article-title":"Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy","volume":"90","author":"Beverung","year":"2015","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.hoc.2016.01.006_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2006.11.003","article-title":"Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines","volume":"21","author":"Josephson","year":"2007","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.hoc.2016.01.006_bib30","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/j.1537-2995.2012.03659.x","article-title":"Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions","volume":"52","author":"Wahl","year":"2012","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.hoc.2016.01.006_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/trf.12875","article-title":"Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease","volume":"55","author":"Michot","year":"2015","journal-title":"Transfusion"},{"issue":"23","key":"10.1016\/j.hoc.2016.01.006_bib32","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle-cell-anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2016.01.006_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1537-2995.1997.37497265337.x","article-title":"Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells","volume":"37","author":"King","year":"1997","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.hoc.2016.01.006_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/ehm.09.2","article-title":"Hyperhemolysis syndrome in sickle cell disease","volume":"2","author":"Win","year":"2009","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2016.01.006_bib35","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2016.01.006_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2016.01.006_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/vox.12217","article-title":"The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease","volume":"108","author":"Noizat-Pirenne","year":"2015","journal-title":"Vox Sang"},{"issue":"6 Pt 2","key":"10.1016\/j.hoc.2016.01.006_bib38","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/trf.12940","article-title":"Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival","volume":"55","author":"Telen","year":"2015","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.hoc.2016.01.006_bib39","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/trf.12585","article-title":"Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease","volume":"54","author":"Kacker","year":"2014","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.hoc.2016.01.006_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/ijlh.12362","article-title":"Frequency and specificity of red cell antibodies in thalassemia patients in Albania","volume":"37","author":"Seferi","year":"2015","journal-title":"Int J Lab Hematol"},{"issue":"9","key":"10.1016\/j.hoc.2016.01.006_bib41","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1537-2995.2006.00946.x","article-title":"Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells","volume":"46","author":"Hendrickson","year":"2006","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.hoc.2016.01.006_bib42","doi-asserted-by":"crossref","first-page":"717.e1","DOI":"10.1016\/j.amjmed.2011.11.028","article-title":"High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease","volume":"125","author":"Papay","year":"2012","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.hoc.2016.01.006_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/vox.12086","article-title":"Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing","volume":"106","author":"Matteocci","year":"2014","journal-title":"Vox Sang"},{"issue":"4","key":"10.1016\/j.hoc.2016.01.006_bib44","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.12348","article-title":"Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)","volume":"54","author":"Vichinsky","year":"2014","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.hoc.2016.01.006_bib45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1537-2995.1985.25285169198.x","article-title":"Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study","volume":"25","author":"Sirchia","year":"1985","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib46","first-page":"50","article-title":"Red cell alloantibodies in patients with thalassemia","volume":"58","author":"Spanos","year":"1990","journal-title":"Vox Sang"},{"issue":"11","key":"10.1016\/j.hoc.2016.01.006_bib47","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1046\/j.1537-2995.2003.00549.x","article-title":"RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients","volume":"43","author":"Ameen","year":"2003","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.hoc.2016.01.006_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/08880018.2011.568595","article-title":"Blood transfusion and alloimmunization in patients with thalassemia: multicenter study","volume":"28","author":"Azarkeivan","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2016.01.006_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.transci.2011.07.014","article-title":"Alloimmunization to red cells in thalassemics: emerging problem and future strategies","volume":"45","author":"Gupta","year":"2011","journal-title":"Transfus Apheresis Sci"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.molimm.2008.12.027","article-title":"rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease","volume":"47","author":"Tatari-Calderone","year":"2009","journal-title":"Mol Immunol"},{"issue":"6","key":"10.1016\/j.hoc.2016.01.006_bib51","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2011-09-382655","article-title":"Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs","volume":"119","author":"Smith","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.2011.08576.x","article-title":"Red cell alloimmunization in a diverse population of transfused patients with thalassaemia","volume":"153","author":"Thompson","year":"2011","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2016.01.006_bib53","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1179\/102453309X12583347114013","article-title":"Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin","volume":"15","author":"Pahuja","year":"2010","journal-title":"Hematology"},{"issue":"12","key":"10.1016\/j.hoc.2016.01.006_bib54","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1182\/blood.V97.12.3999","article-title":"Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients","volume":"97","author":"Ho","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2016.01.006_bib55","unstructured":"NIH, NHLBI. Evidence-based management of sickle cell disease: expert panel report. 2014. Available at: http:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/sickle-cell-disease-guidelines\/. Accessed August 24, 2015."},{"issue":"10","key":"10.1016\/j.hoc.2016.01.006_bib56","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.hoc.2016.01.006_bib57","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1537-2995.2001.41091086.x","article-title":"Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial","volume":"41","author":"Vichinsky","year":"2001","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.hoc.2016.01.006_bib58","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":"Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)","volume":"51","author":"Lasalle-Williams","year":"2011","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.hoc.2016.01.006_bib59","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1537-2995.1994.34794330008.x","article-title":"Antigen-matched donor blood in the transfusion management of patients with sickle-cell disease","volume":"34","author":"Tahhan","year":"1994","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/trf.12924","article-title":"Prospective antigen matching strategies fail to fit the model","volume":"55","author":"Webb","year":"2015","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.hoc.2016.01.006_bib61","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2016.01.006_bib62","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1537-2995.2008.01855.x","article-title":"Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time","volume":"48","author":"Denomme","year":"2008","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5581\/1516-8484.20130012","article-title":"Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients","volume":"35","author":"da Costa","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"10","key":"10.1016\/j.hoc.2016.01.006_bib64","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V96.10.3369","article-title":"Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent","volume":"96","author":"Singer","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2016.01.006_bib65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1537-2995.2011.03234.x","article-title":"Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program","volume":"52","author":"el-Danasoury","year":"2012","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.hoc.2016.01.006_bib66","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1046\/j.1537-2995.2002.00234.x","article-title":"Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management","volume":"42","author":"Shirey","year":"2002","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.hoc.2016.01.006_bib67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1537-2995.2008.02014.x","article-title":"The persistence and evanescence of blood group alloantibodies in men","volume":"49","author":"Tormey","year":"2009","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.hoc.2016.01.006_bib68","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1537-2995.2012.03796.x","article-title":"Red blood cell alloimmunization in sickle cell disease: prevalence in 2010","volume":"53","author":"Miller","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2016.01.006_bib69","unstructured":"FDA, US Department of Health and Human Services. Fatalities reported to the\u00a0FDA following blood collection. 2012. Available at: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/SafetyAvailability\/ReportaProblem\/TransfusionDonationFatalities\/default.htm. Accessed August 24, 2015."}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858816000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858816000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:03:11Z","timestamp":1760184191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858816000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0889858816000071"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2016.01.006","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red Blood Cell Antibodies in Hematology\/Oncology Patients","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}